Home/Filings/4/0001209191-22-020655
4//SEC Filing

LaRocca John 4

Accession 0001209191-22-020655

CIK 0001337553other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 8:29 PM ET

Size

7.4 KB

Accession

0001209191-22-020655

Insider Transaction Report

Form 4
Period: 2022-03-18
LaRocca John
General Counsel
Transactions
  • Award

    Common Stock

    2022-03-18+19,01554,356 total
  • Award

    Stock Option (right to buy)

    2022-03-18+65,94165,941 total
    Exercise: $8.80Exp: 2032-03-18Common Stock (65,941 underlying)
Footnotes (2)
  • [F1]These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of March 18, 2022.
  • [F2]This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of March 18, 2022.

Issuer

AERIE PHARMACEUTICALS INC

CIK 0001337553

Entity typeother

Related Parties

1
  • filerCIK 0001732197

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 8:29 PM ET
Size
7.4 KB